Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells
Liv Johannessen, Thomas B. Sundberg, Daniel J. O’Connell, et al.
Nature Chemical Biology (2017) Vol. 13, Iss. 10, pp. 1102-1108
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Kinase inhibitors: the road ahead
Fleur M. Ferguson, Nathanael S. Gray
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 5, pp. 353-377
Closed Access | Times Cited: 892
Kinase inhibition in autoimmunity and inflammation
Ali A. Zarrin, Katherine Bao, Patrick J. Lupardus, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 1, pp. 39-63
Open Access | Times Cited: 336
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)
Concepción Sánchez‐Martínez, Marı́a José Lallena, Sonia Gutiérrez Sanfeliciano, et al.
Bioorganic & Medicinal Chemistry Letters (2019) Vol. 29, Iss. 20, pp. 126637-126637
Closed Access | Times Cited: 178
Small-molecule targeting of brachyury transcription factor addiction in chordoma
Tanaz Sharifnia, Mathias J. Wawer, Ting Chen, et al.
Nature Medicine (2019) Vol. 25, Iss. 2, pp. 292-300
Open Access | Times Cited: 147
The Mediator kinase module: an interface between cell signaling and transcription
Olivia Luyties, Dylan J. Taatjes
Trends in Biochemical Sciences (2022) Vol. 47, Iss. 4, pp. 314-327
Open Access | Times Cited: 76
Immunomodulation by anticancer cell cycle inhibitors
Giulia Petroni, Silvia C. Formenti, Selina Chen‐Kiang, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 11, pp. 669-679
Open Access | Times Cited: 118
Regulatory functions of the Mediator kinases CDK8 and CDK19
Charli B. Fant, Dylan J. Taatjes
Transcription (2018) Vol. 10, Iss. 2, pp. 76-90
Open Access | Times Cited: 103
Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy?
Stephen Philip, Malika Kumarasiri, Theodosia Teo, et al.
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 12, pp. 5073-5092
Closed Access | Times Cited: 99
Therapeutic targeting of transcriptional cyclin-dependent kinases
Matthew D. Galbraith, Heather Bender, Joaquı́n M. Espinosa
Transcription (2018) Vol. 10, Iss. 2, pp. 118-136
Open Access | Times Cited: 91
Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions
Iris Steinparzer, Vitaly Sedlyarov, Jonathan D. Rubin, et al.
Molecular Cell (2019) Vol. 76, Iss. 3, pp. 485-499.e8
Open Access | Times Cited: 82
Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6356-6389
Closed Access | Times Cited: 46
CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases
Jiaxin Liang, Mengqian Chen, Daniel Hughes, et al.
Cancer Research (2018) Vol. 78, Iss. 23, pp. 6594-6606
Open Access | Times Cited: 80
Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies
Zi Wang, Pan Wang, Yanan Li, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 51
Nuisance compounds in cellular assays
Jayme L. Dahlin, Douglas S. Auld, Ina Rothenaigner, et al.
Cell chemical biology (2021) Vol. 28, Iss. 3, pp. 356-370
Open Access | Times Cited: 49
CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors
Meiyang Xi, Tingkai Chen, Chunlei Wu, et al.
European Journal of Medicinal Chemistry (2018) Vol. 164, pp. 77-91
Closed Access | Times Cited: 53
Inhibition of Cdk8/Cdk19 Activity Promotes Treg Cell Differentiation and Suppresses Autoimmune Diseases
Zengli Guo, Gang Wang, Yan-Fang Lv, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 44
The gut protist Tritrichomonas arnold restrains virus-mediated loss of oral tolerance by modulating dietary antigen-presenting dendritic cells
Luzmariel Medina Sanchez, Magdalena Siller, Yanlin Zeng, et al.
Immunity (2023) Vol. 56, Iss. 8, pp. 1862-1875.e9
Open Access | Times Cited: 13
Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model
Antara Rao, Nuo Chen, Min Joo Kim, et al.
Cell stem cell (2024)
Open Access | Times Cited: 5
Hit Triage and Validation in Phenotypic Screening: Considerations and Strategies
Fabien Vincent, Paula M. Loria, Andrea D. Weston, et al.
Cell chemical biology (2020) Vol. 27, Iss. 11, pp. 1332-1346
Open Access | Times Cited: 39
Transcriptional cyclin-dependent kinases as the mediators of inflammation-a review
Vaishnavi Sundar, Sanjana Vimal, M.s. Sai Mithlesh, et al.
Gene (2020) Vol. 769, pp. 145200-145200
Closed Access | Times Cited: 33
CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells
Riley M. Horvath, Zabrina L. Brumme, Ivan Sadowski
Journal of Virology (2023) Vol. 97, Iss. 9
Open Access | Times Cited: 12
Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies
Xiaomin Yin, Zhilong He, Kun Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
The discovery of a novel pyrrolo[2,3-b]pyridine as a selective CDK8 inhibitor offers a new approach against psoriasis
Yao Yao Yan, Yumeng Wang, Jun Hao Shen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116705-116705
Open Access | Times Cited: 4
Phenotype-Led Identification of IL-10 Upregulators in Human CD4+ T-cells and Elucidation of Their Pharmacology as Highly Selective CDK8/CDK19 Inhibitors
Simon Nicolle, Mike D. Barker, J. Carl Barrett, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
CDK8 mediated inflammatory microenvironment aggravates osteoarthritis progression
Zhongnan Lin, Yining Xu, Hongyi Jiang, et al.
Journal of Advanced Research (2025)
Open Access
Page 1 - Next Page

Scroll to top